NeoImmuneTech, Inc. (KOSDAQ: 950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,112.00
-14.00 (-1.24%)
Dec 20, 2024, 9:00 AM KST

NeoImmuneTech Company Description

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.

It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases.

The company was incorporated in 2014 and is headquartered in Rockville, Maryland.

NeoImmuneTech, Inc.
Country South Korea
Founded 2014
Industry Biological Products, Except Diagnostic Substances
Employees 82
CEO Luke Yun Oh

Contact Details

Address:
2400 Research Blvd.
Rockville, 20850
United States
Phone 240 801 9065
Website neoimmunetech.com

Stock Details

Ticker Symbol 950220
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2836

Key Executives

Name Position
Luke Yun Oh Chief Executive Officer
Tae Woo Kim Chief Financial Officer
Goongjin Namgoong Chief Operating Officer